zoledronic acid has been researched along with Pericementitis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 9 (52.94) | 24.3611 |
2020's | 5 (29.41) | 2.80 |
Authors | Studies |
---|---|
Gwack, Y; Ho, K; Kim, RH; Kim, S; Kim, T; Lenon, A; Williams, DW | 1 |
Cheong, J; Kim, KD; Lee, JS; Pang, NS; Park, KM; Park, W | 1 |
Chen, H; Chen, Y; Duan, Y; Jin, C; Li, D; Li, J; Qian, J; Shuai, T; Wu, Y; Zhang, M | 1 |
Abraham, AM; Aguirre, JI; Bhattacharyya, I; Castillo, EJ; Israel, R; Jiron, JM; Jorgensen, M; Kimmel, DB; Messer, JG; Reynolds, MC; Thomas, S; Van Poznak, C; Wanionok, N; Wnek, RD; Yarrow, JF | 1 |
Abraham, AM; Aguirre, JI; Alekseyenko, AV; Bhattacharyya, I; Castillo, EJ; Croft, S; Gohel, A; Gonzalez-Perez, GM; Israel, R; Jiron, JM; Kimmel, DB; Messer, JG; Novince, CM; Thomas, S; Yarrow, JF | 1 |
Aghaloo, T; Bezouglaia, O; Christensen, R; Dry, SM; Esfandi, N; Gkouveris, I; Hadaya, D; Nikitakis, N; Pirih, F; Soundia, A; Tetradis, S | 1 |
Aguirre, JI; Bhattacharyya, N; Castillo, EJ; Jiron, JM; Kimmel, DB; Mendieta Calle, JL; Messer, JG; Van Poznak, C | 1 |
Chatani, M; Funatsu, T; Isawa, M; Karakawa, A; Kuritani, M; Negishi-Koga, T; Sakai, N; Takami, M | 1 |
Agamennone, M; Campestre, C; Cataldi, A; De Colli, M; Loiodice, F; Tortorella, P; Zara, S | 1 |
Aghaloo, TL; Bezouglaia, O; Boyce, RW; Dry, SM; Dwyer, D; Gkouveris, I; Hadaya, D; Pirih, FQ; Soundia, A; Stolina, M; Tetradis, S | 1 |
Aguirre, JI; Castillo, EJ; Israel, R; Jiron, JM; Kesavalu, L; Kimmel, DB; Mendieta Calle, JL; Messer, JG; Phillips, EG; Van Poznak, C; Yarrow, JF | 1 |
Allen, MR; Chen, NX; Gattone, VH; Moe, SM | 1 |
Huo, L; Li, CL; Lu, WW; Seneviratne, CJ; Zheng, LW | 1 |
Aguirre, JI; Akhter, MP; Jorgensen, M; Kesavalu, L; Kimmel, DB; Pingel, JE; Williams, A; Wronski, TJ | 1 |
Broumand, V; Fortin, M; Marx, RE; Sawatari, Y | 1 |
Soileau, KM | 1 |
Braun, E; Iacono, VJ | 1 |
17 other study(ies) available for zoledronic acid and Pericementitis
Article | Year |
---|---|
Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Mice; Osteonecrosis; Periodontitis; Tooth Extraction; Zoledronic Acid | 2022 |
Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Periodontitis; Rats; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2023 |
CREB1 alleviates the apoptosis and potentiates the osteogenic differentiation of zoledronic acid-treated human periodontal ligament stem cells via up-regulating VEGF.
Topics: Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Humans; Osteogenesis; Periodontal Ligament; Periodontitis; Signal Transduction; Sincalide; Stem Cells; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2023 |
Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris).
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Male; Osteonecrosis; Periodontitis; Rats; Sigmodontinae; X-Ray Microtomography; Zoledronic Acid | 2020 |
Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Humans; Jaw; Male; Osteonecrosis; Periodontitis; Rats; Sigmodontinae; Zoledronic Acid | 2021 |
Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis.
Topics: Aged; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Female; Humans; Immunohistochemistry; Periodontitis; Rats; Rats, Wistar; Tooth Extraction; Tooth Socket; Wound Healing; X-Ray Microtomography; Zoledronic Acid | 2018 |
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Body Weight; Bone Resorption; Dose-Response Relationship, Drug; Female; Femur; Osteocytes; Periodontitis; Prevalence; Sigmodontinae; Treatment Outcome; Zoledronic Acid | 2018 |
Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice.
Topics: Alveolar Bone Loss; Animals; Antibodies; Diphosphonates; Disease Models, Animal; Imidazoles; Lipopolysaccharides; Male; Mice, Inbred C57BL; Osteoclasts; Periodontitis; RANK Ligand; Skull; Zoledronic Acid | 2018 |
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study.
Topics: Cell Death; Cell Membrane; Collagen Type I; Culture Media; Diphosphonates; Fibroblasts; Gingiva; Humans; Imidazoles; Inflammation; Lipopolysaccharides; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Periodontitis; Zoledronic Acid | 2018 |
Clinically Relevant Doses of Sclerostin Antibody Do Not Induce Osteonecrosis of the Jaw (ONJ) in Rats with Experimental Periodontitis.
Topics: Animals; Antibodies; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Morphogenetic Proteins; Female; Genetic Markers; Osteoporosis; Ovariectomy; Periodontitis; Rats; Rats, Sprague-Dawley; Zoledronic Acid | 2019 |
Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Dose-Response Relationship, Drug; Duration of Therapy; Periodontitis; Prevalence; Rats; Sigmodontinae; Zoledronic Acid | 2019 |
Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.
Topics: Animals; Bone Diseases; C-Reactive Protein; Calcium; Dental Cementum; Dental Enamel; Diphosphonates; Disease Models, Animal; Heterozygote; Imidazoles; Inflammation; Kidney Diseases; Male; Mandible; Parathyroid Hormone; Periodontitis; Phenotype; Rats; Tomography, X-Ray Computed; X-Ray Microtomography; Zoledronic Acid | 2013 |
Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis.
Topics: Actinomyces; Actinomycosis; Alveolar Bone Loss; Animals; Bacterial Load; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density; Bone Density Conservation Agents; Cancellous Bone; Diphosphonates; Disease Models, Animal; Disease Progression; Female; Imidazoles; Mandibular Diseases; Ovariectomy; Periodontitis; Random Allocation; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2015 |
Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
Topics: Alendronate; Animals; Apoptosis; Bisphosphonate-Associated Osteonecrosis of the Jaw; Cell Count; Diphosphonates; Dose-Response Relationship, Drug; Imidazoles; Mandible; Osteoclasts; Osteocytes; Osteogenesis; Periodontitis; Sigmodontinae; Zoledronic Acid | 2012 |
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Dental Caries; Dexamethasone; Diphosphonates; Drug Interactions; Female; Humans; Hyperostosis; Imidazoles; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Osteopetrosis; Osteoporosis; Pamidronate; Periodontitis; Prostatic Neoplasms; Risk Factors; Tooth Extraction; Zoledronic Acid | 2005 |
Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy.
Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Periodontitis; Zoledronic Acid | 2006 |
Bisphosphonates: case report of nonsurgical periodontal therapy and osteochemonecrosis.
Topics: Alveolar Bone Loss; Bone Density Conservation Agents; Dental Scaling; Diphosphonates; Humans; Imidazoles; Male; Mandibular Diseases; Middle Aged; Oral Fistula; Osteonecrosis; Periodontitis; Root Planing; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2006 |